Veritable’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-10,580
Closed -$163K 820
2018
Q4
$163K Buy
+10,580
New +$217K ﹤0.01% 745
2016
Q3
Sell
-5,216
Closed -$262K 746
2016
Q2
$262K Buy
5,216
+26
+0.5% +$1.38K 0.01% 603
2016
Q1
$278K Sell
5,190
-4,959
-49% -$291K 0.01% 590
2015
Q4
$666K Buy
10,149
+4,939
+95% +$305K 0.02% 393
2015
Q3
$294K Buy
5,210
+20
+0.4% +$1.3K 0.01% 582
2015
Q2
$307K Sell
5,190
-10,396
-67% -$641K 0.01% 598
2015
Q1
$971K Sell
15,586
-122
-0.8% -$7.09K 0.02% 414
2014
Q4
$903K Sell
15,708
-376
-2% -$20.9K 0.02% 429
2014
Q3
$865K Sell
16,084
-577
-3% -$30.6K 0.02% 444
2014
Q2
$873K Buy
16,661
+2,552
+18% +$130K 0.02% 435
2014
Q1
$746K Buy
14,109
+111
+0.8% +$5.13K 0.02% 469
2013
Q4
$561K Sell
13,998
-6,689
-32% -$263K 0.01% 547
2013
Q3
$782K Buy
20,687
+569
+3% +$22.2K 0.02% 446
2013
Q2
$789K Buy
+20,118
New +$783K 0.02% 454

Other funds holding TEVA